{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:01:57Z","timestamp":1792180917140,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100020970","name":"Johnson & Johnson Consumer Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020970","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s40266-024-01108-x","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T11:02:34Z","timestamp":1711191754000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Patterns of Comorbidities and Prescribing and Dispensing of Non-steroidal Anti-inflammatory Drugs (NSAIDs) Among Patients with Osteoarthritis in the USA: Real-World Study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9646-4077","authenticated-orcid":false,"given":"Joshua","family":"Ide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza","family":"Shoaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,23]]},"reference":[{"key":"1108_CR1","unstructured":"Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. OA affects over 32.5 million US adults. Page last reviewed: July 27, 2020. Available from: https:\/\/www.cdc.gov\/arthritis\/index.htm. Accessed 17 Feb 2023."},{"key":"1108_CR2","unstructured":"Mayo Clinic. Patient care & health information: diseases & conditions. Osteoarthritis. Available from: https:\/\/www.mayoclinic.org\/diseases-conditions\/osteoarthritis\/symptoms-causes\/syc-20351925. Accessed 17 Feb 2023."},{"issue":"2","key":"1108_CR3","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1097\/j.pain.0000000000002291","volume":"163","author":"RJ Young","year":"2022","unstructured":"Yong RJ, Mullins PM, Bhattacharyya N. Prevalence of chronic pain among adults in the United States. Pain. 2022;163(2):e328\u2013422. https:\/\/doi.org\/10.1097\/j.pain.0000000000002291.","journal-title":"Pain"},{"issue":"11","key":"1108_CR4","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1002\/acr.25157","volume":"75","author":"Z Yang","year":"2023","unstructured":"Yang Z, Mathieson S, Kobayashi S, Shaheed CA, Nogueira LAG, Simic M, et al. Prevalence of nonsteroidal antiinflammatory drugs prescribed for osteoarthritis: a systematic review and meta-analysis of observational studies. Arthritis Care Res (Hoboken). 2023;75(11):2345\u201358. https:\/\/doi.org\/10.1002\/acr.25157.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"3","key":"1108_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.rdc.2022.03.009","volume":"48","author":"C Overton","year":"2022","unstructured":"Overton C, Nelson AE, Neogi T. Osteoarthritis treatment guidelines from six professional societies: similarities and differences. Rheum Dis Clin North Am. 2022;48(3):637\u201357. https:\/\/doi.org\/10.1016\/j.rdc.2022.03.009.","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"1108_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/acr.23884","volume":"72","author":"MC Osani","year":"2020","unstructured":"Osani MC, Vaysbrot EE, Zhou M, McAlindon TE, Bannuru RR. Duration of symptom relief and early trajectory of adverse events for oral nonsteroidal antiinflammatory drugs in knee osteoarthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2020;72(5):641\u201351. https:\/\/doi.org\/10.1002\/acr.23884.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"2","key":"1108_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/acr.24131","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72(2):149\u201362. https:\/\/doi.org\/10.1002\/acr.24131.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"1108_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2321","volume":"375","author":"BR da Costa","year":"2021","unstructured":"da Costa BR, Pereira TV, Saadat P, Rudnicki M, Iskander SM, Bodmer NS, et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021;375: n2321. https:\/\/doi.org\/10.1136\/bmj.n2321.","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"1108_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40266-019-00660-1","volume":"36","author":"C Cooper","year":"2019","unstructured":"Cooper C, Chapurlat R, Al-Daghri N, Herrero-Beaumont G, Bruy\u00e8re O, Rannou F, et al. Safety of oral non selective non steroidal anti inflammatory drugs in osteoarthritis: what does the literature say? Drugs Aging. 2019;36(Suppl. 1):15\u201324. https:\/\/doi.org\/10.1007\/s40266-019-00660-1.","journal-title":"Drugs Aging"},{"key":"1108_CR10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/2327-6924.12139","volume":"26","author":"TO Fowler","year":"2014","unstructured":"Fowler TO, Durham CO, Planton J, Edlund BJ. Use of nonsteroidal-anti-inflammatory drugs in the older adult. J Am Assoc Nurse Pract. 2014;26:414\u201323. https:\/\/doi.org\/10.1002\/2327-6924.12139.","journal-title":"J Am Assoc Nurse Pract"},{"key":"1108_CR11","first-page":"574","volume":"216","author":"G Hripcsak","year":"2015","unstructured":"Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574\u20138.","journal-title":"Stud Health Technol Inform."},{"issue":"3","key":"1108_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/jamia\/ocu023","volume":"22","author":"EA Voss","year":"2015","unstructured":"Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553\u201364. https:\/\/doi.org\/10.1093\/jamia\/ocu023.","journal-title":"J Am Med Inform Assoc"},{"issue":"10","key":"1108_CR13","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/jamia\/ocab132","volume":"28","author":"C Blacketer","year":"2021","unstructured":"Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021;28(10):2251\u20137. https:\/\/doi.org\/10.1093\/jamia\/ocab132.","journal-title":"J Am Med Inform Assoc"},{"key":"1108_CR14","unstructured":"Rui P, Okeyode T. National ambulatory medical survey: 2015 state and national summary tables. Available from: https:\/\/www.cdc.gov\/nchs\/data\/ahcd\/namcs_summary\/2015_namcs_web_tables.pdf. Accessed 24 Nov 2023."},{"key":"1108_CR15","unstructured":"Centers for Disease Control and Prevention. National Center for Environmental Health. Asthma data, statistics, and surveillance: most recent asthma data. Available from: https:\/\/www.cdc.gov\/asthma\/most_recent_data.htm. Accessed 24 Nov 2023."},{"key":"1108_CR16","unstructured":"Centers for Disease Control and Prevention. National Center for Health Statistics. Percentage of heart attack for adults aged 18 and over (95% confidence intervals), United States, 2019\u20132021. National health interview survey. Available from: https:\/\/wwwn.cdc.gov\/NHISDataQueryTool\/SHS_adult\/index.html. Accessed 24 Nov 2023."},{"key":"1108_CR17","unstructured":"Centers for Disease Control and Prevention. National Center for Health Statistics. Percentage of coronary heart disease for adults aged 18 and over (95% confidence intervals), United States, 2019\u20132021. National health interview survey. Available from: https:\/\/wwwn.cdc.gov\/NHISDataQueryTool\/SHS_adult\/index.html. Accessed 24 Nov 2023."},{"key":"1108_CR18","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/MCG.0000000000000208","volume":"49","author":"S Scaglione","year":"2015","unstructured":"Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, et al. The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol. 2015;49:690\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"1108_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.e0232346","volume":"15","author":"D Newman","year":"2020","unstructured":"Newman D, Tong M, Levine E, Kishore S. Prevalence of multiple chronic conditions by US state and territory, 2017. PLoS ONE. 2020;15(5):e0232346. https:\/\/doi.org\/10.1371\/journal.e0232346.","journal-title":"PLoS ONE"},{"key":"1108_CR20","doi-asserted-by":"publisher","DOI":"10.5888\/pcd17.200130","volume":"17","author":"P Boersma","year":"2020","unstructured":"Boersma P, Black LI, Ward BW. Prevalence of multiple chronic conditions among US adults, 2018. Prev Chronic Dis. 2020;17: 200130. https:\/\/doi.org\/10.5888\/pcd17.200130.","journal-title":"Prev Chronic Dis"},{"key":"1108_CR21","unstructured":"Zelaya CE, Dahlhamer JM, Lucas JW, Connor EM. Chronic pain and high-impact chronic pain among US adults, 2019. NCHS Data Brief, no 390. Hyattsville, MD: National Center for Health Statistics; 2020. Available from:  https:\/\/www.chromeextension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/. https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db390-H.pdf. Accessed 24 Nov 2023."},{"issue":"1","key":"1108_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14336\/AD.2017.0306","volume":"9","author":"S Wongrakpanich","year":"2018","unstructured":"Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1):143\u201350. https:\/\/doi.org\/10.14336\/AD.2017.0306.","journal-title":"Aging Dis"},{"issue":"4","key":"1108_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1370\/afm.1644","volume":"12","author":"T Williamson","year":"2014","unstructured":"Williamson T, Green ME, Birtwhistle R, Khan S, Garies S, Wong ST, et al. Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records. Ann Fam Med. 2014;12(4):367\u201372. https:\/\/doi.org\/10.1370\/afm.1644.","journal-title":"Ann Fam Med"},{"key":"1108_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12911-016-0319-y","volume":"16","author":"S Shrestha","year":"2016","unstructured":"Shrestha S, Dave AJ, Losina E, Katz JN. Diagnostic accuracy of administrative data algorithms in the diagnosis of osteoarthritis: a systematic review. BMC Med Inform Decis Mak. 2016;16:82. https:\/\/doi.org\/10.1186\/s12911-016-0319-y.","journal-title":"BMC Med Inform Decis Mak"},{"key":"1108_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c7086","volume":"342","author":"S Trelle","year":"2011","unstructured":"Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, et al. Cardiovascular safety of non-steroidal anti-inflammatory drug: network meta-analysis. BMJ. 2011;342: c7086. https:\/\/doi.org\/10.1136\/bmj.c7086.","journal-title":"BMJ"},{"issue":"12","key":"1108_CR26","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2165\/11633470-000000000-00000","volume":"35","author":"J Castellsague","year":"2012","unstructured":"Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Regalt A, Nicotra F, on behalf of the investigators of the Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35(12):1127\u201346. https:\/\/doi.org\/10.2165\/11633470-000000000-00000.","journal-title":"Drug Saf"},{"key":"1108_CR27","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"Coxib and traditional NSAID Trialists\u2019 (CNT) Collaboration","year":"2013","unstructured":"Coxib and traditional NSAID Trialists\u2019 (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomized trials. Lancet. 2013;382:769\u201379. https:\/\/doi.org\/10.1016\/S0140-6736(13)60900-9.","journal-title":"Lancet"},{"key":"1108_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1053\/j.ajkd.2004.12.005","volume":"45","author":"C Huerta","year":"2005","unstructured":"Huerta C, Castellsague J, Varas-Lorenzo C, Garcia Rodriguez LA. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis. 2005;45:531\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1108_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12882-017-0673-8","volume":"18","author":"X Zhang","year":"2017","unstructured":"Zhang X, Donnan PT, Bell S, Guthrie B. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol. 2017;18:256. https:\/\/doi.org\/10.1186\/s12882-017-0673-8.","journal-title":"BMC Nephrol"},{"key":"1108_CR30","unstructured":"US Food and Drug Administration. Drug safety and availability. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. Available from: https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm451800.htm. Accessed 24 Nov 2023."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01108-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01108-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01108-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T11:39:43Z","timestamp":1713267583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01108-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,23]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01108-x","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,23]]},"assertion":[{"value":"7 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division, provided funding for the study and for support by an independent medical writer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors were employees of or consultants to Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division or Janssen Research and Development, LLC, a subsidiary of Johnson & Johnson.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"The New England Institutional Review Board (NEIRB) determined that analyses conducted with the Optum database (NEIRB 12-286) or the MarketScan databases (NEIRB 12-284) do not meet the definition of human subject research, and therefore institutional review board review and approval were not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"De-identified patient-level data were obtained through a commercial license agreement with each data holder and are therefore not immediately available for further dissemination.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"JI: protocol\/study design, study execution, data review and analysis, critical review and revision of manuscript, final approval of version to be published, agreement to be accountable for all aspects of work and that questions are appropriately investigated and resolved. AS: data review and analysis, critical review and revision of manuscript, final approval of version to be published, agreement to be accountable for all aspects of work and that questions are appropriately investigated and resolved. KEB: drafting manuscript, data review and analysis, critical review and revision of manuscript, final approval of version to be published, agreement to be accountable for all aspects of work and that questions are appropriately investigated and resolved. KW: protocol\/study design, data review and analysis, critical review and revision of manuscript, final approval of version to be published, agreement to be accountable for all aspects of work and that questions are appropriately investigated and resolved. RW: protocol\/study design, data review and analysis, drafting manuscript, critical review and revision of manuscript, final approval of version to be published, agreement to be accountable for all aspects of work and that questions are appropriately investigated and resolved. AM: protocol\/study design, data review and analysis, critical review and revision of manuscript, final approval of version to be published, agreement to be accountable for all aspects of work and that questions are appropriately investigated and resolved. All authors had full access to the study data and had final responsibility to submit the manuscript for publication.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}